CASE HISTORY: CORECTIM® (DELGOCITINIB), THE FIRST TOPICAL JAK INHIBITOR FOR THE TREATMENT OF ATOPIC DERMATITIS
用户6X7Ch8WUQ_gI
2个月前
40
10
已关闭
DOI: DOI: 10.1021/mc-2023-vol58.ch22
文献链接: https://pubs.acs.org/doi/10.1021/mc-2023-vol58.ch22
其他信息:
出版社: MEDI, Inc. Published by American Chemical Society.
作者: Makoto Shiozaki

